FDA Drug Safety Update: Key Takeaways From IoM Workshop
This article was originally published in RPM Report
Executive Summary
It has been three years since an Institute of Medicine report on FDA's drug safety system, and two years since the landmark FDA Amendments Act that followed. As those anniversaries approached, IoM convened a workshop for an update on the changes at FDA since FDAAA. Here's what we heard.
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: